Kelly W Padilla is an Advisor at TruLab. Kelly was previously with GSK from October 2013 to October 2017, where they served as Global Medical Information - Respiratory. In this role, they were responsible for the global medical letter database utilized by other GSK Local Operating Companies. Kelly also contributed to the design of global Phase IV trials and evidence generation plans. Prior to this, they served as Medical Information Scientist, where they worked collaboratively with GSK personnel in Sales, Marketing, Clinical Research, Global Safety and Medical Affairs to support the product launch of an ICS and ICS/LABA in asthma. Kelly was also the U.S. MI-payer lead for two launch assets in asthma and COPD. Kelly has a wealth of experience in handling clinical information queries from healthcare providers and training various internal customer groups.
Kelly W Padilla received their Doctor of Pharmacy (PharmD) from UNC-Chapel Hill & Univ of Florida. Kelly also holds a BS in Pharmacy from University of North Carolina at Chapel Hill and a Doctor of Pharmacy from University of Florida. Kelly is a graduate of North Carolina School of Science and Mathematics.
This person is not in the org chart